" "
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Vaccine for Killer Disease One Step Closer

Published: Monday, November 19, 2012
Last Updated: Sunday, November 18, 2012
Bookmark and Share
New 4CMenB vaccine designed to cover most strains of the disease in Europe.

Leading meningitis charity Meningitis Research Foundation (MRF) has welcomed the news that a potentially lifesaving vaccine to prevent MenB is one step closer with positive opinion by the European Medicines Agency (EMA).

The vaccine, 4CMenB produced by Novartis Vaccines and Diagnostics Limited is the first ever vaccine against meningococcal B meningitis and septicaemia (MenB) designed to cover most strains of the disease in Europe.

MenB is responsible for an average of 1870 cases across the UK each year, mostly in young children.

Around 1 in 10 people affected will die, and a further 1 in 10 survivors will be left with serious after-effects, such as limb amputations, deafness, blindness, and brain damage.

The new vaccine will require a license from the European Commission before European governments can consider it for implementation.

The UK Government takes vaccination advice from the Joint Committee on Vaccination and Immunization.

If they recommend the new MenB vaccine, the earliest it could be implemented in the UK would be the end of 2013.

Chris Head, Chief Executive of Meningitis Research Foundation said: “We have a vision of a world free from meningitis and septicaemia so this news is a huge boost for our members and their families, and for doctors and scientists who have all worked tirelessly against this devastating disease. Since the first meningitis vaccine was introduced in 1992, many strains of meningitis including Hib, MenC and pneumococcal have been dramatically reduced. Once the MenB vaccine is licensed, it is essential that Government give it full consideration as soon as possible, especially given the shocking lifetime costs to people who survive MenB and are left with serious, life-long disabilities. We must not allow children to die from this disease if it can be prevented.”

MRF Trustee Professor George Griffin, professor of Infectious Diseases and Medicine at St George’s University of London said: “This vaccine is a real step forward and will have a major impact on MenB cases. However, meningitis will remain a major clinical problem and research into microbial causes continues to be a priority alongside raising public awareness of the symptoms.”

Paralympics reporter and keen equestrian Diana Man (30) from Tunbridge Wells is building a new life after contracting MenB in November 2007 which left her without her lower legs, her fingers and with epilepsy.

She said: “My life has changed a great deal since getting MenB, but I have learned to adjust and manage just like anyone else. If a vaccine has been produced to prevent this disease it should be made available as soon as possible to prevent anyone else having to face the difficulties myself and others face in the future both physically, emotionally and financially.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!